|
Indian Pediatr 2020;57:907-909 |
 |
Progression of
Thyrotropinemia in Overweight and Obese Children From Puducherry,
India
|
Srinivasan Thiagarajan, 1
Thirunavukkarasu Arun Babu2
and Rajeshwar Balaji1
From Departments of Pediatrics, 1Indira Gandhi Medical
College and Research Institute (IGMC&RI), Puducherry, India; and
2All India Institute of Medical Sciences, Mangalagiri, Andhra
Pradesh, India.
Correspondence to: Dr Thirunavukarasu Arun Babu, Associate Professor,
Department of Pediatrics, AIIMS, Mangalagiri, 522 503, Andhra Pradesh,
India.
Email: [email protected]
Received: June 06, 2019;
Initial review: October 09, 2019;
Accepted: April 29, 2020.
|
Objective: To assess the progression of thyrotropinemia to overt
hypothyroidism in overweight and obese children. Methods: 150
overweight and obese children aged 5-15 years were enrolled. Free T4 and
thyroid stimulating hormone (TSH) were done at enrollment and for those
with TSH >5 mIU/L, TSH levels were repeated after 1 year. Results:
The mean (SD) body mass index (BMI) and TSH were 23.8 (3.19) kg/m2 and
2.70 (2.44) mIU/L, respectively. 17 children had thyrotropinemia (TSH
between 10-15mIU/L); 10 (84.6%) of these children attained normal TSH
levels at one year follow-up, and none progressed to overt
hypothyroidism (TSH >15 mlU/L). Conclusion: Levels of 5-15 mIU/L
are common in asymptomatic overweight and obese children. Majority of
these children revert back to normal TSH levels on follow-up.
Keywords: Body mass index, Metabolic syndrome, Sub-clinical
hypothyroidism, Thyroid stimulating hormone.
|
C omprehensive National Nutrition Survey
(CNNS) 2016-18 reported that 4% of all school age children and
5% of adolescents were overweight based on body mass index (BMI)
[1]. Subclinical hypothyroidism (SCH) is very common in
overweight and obese children and has an estimated prevalence of
about 9% compared to 6.1% in non-obese children in India [2-4].
Risk factors for SCH are female sex, Hashimoto thyroiditis,
reduced iodide intake, radiation exposure, etc [2].
Diagnosing SCH in obese children remains
contro-versial as increased TSH levels (thyrotropinemia) are
frequently present in obese children [4,5]. Although, the exact
mechanism of TSH elevation in obesity is unclear, some studies
have attributed thyrotropinemia to increased deiodinase levels
converting T4 to T3 as a compensatory mechanism to increase
basal metabolic rate, and reduced expression of TSH and T4
receptors in adipose tissue of obese children [6]. Two large
population-based studies from India reporting normograms for TSH
in normal Indian children are available [3], but there is no
consensus in cut-off levels of TSH for obese children [7,8].
Thyroxine replacement for marginal elevations
of TSH in childhood obesity has questionable benefits [9].
Obesity may be associated with TSH surge but it does not signify
hypothyroidism in all cases. It is unclear if SCH (thyrotropinemia)
progresses into overt hypothyroidism in obese children
[2].Though there are various studies evaluating the intriguing
relationship between fT4 and BMI in childhood obesity, the
findings are inconsistent [6-8]. Therefore, we studied the
progression of thyrotropinemia (SCH) to overt hypothyroidism in
obese and overweight children.
METHODS
This longitudinal study was conducted from
July, 2018 to July, 2019 at a tertiary care pediatric hospital
in Puducherry, India. Children between 5-15 years of age
attending the pediatric out patient department with body mass
index (BMI) more than 23 kg/m 2
adult equivalent according to standards for Indian children
[10]. Children with BMI between 23 to 27 kg/m2and
>27 kg/m2 were
categorized as overweight and obese, respectively. Children on
anti-thyroid medication, family history of thyroid disorders,
and sick children with acute illness requiring admission were
excluded from the study. Approval from Institute’s research and
ethics committee were obtained before commencement of the study.
Informed written consent was obtained from the parents and
assent from older children.
All children were checked for presence of
goiter and symptoms of hypothyroidism like constipation, dry
skin, cold intolerance, hair loss, hoarse voice and growth
retardation.Weight, height, waist circumference and hip
circumference measurements were recorded. Enrolled children were
screened for hypothyroidism with free T4 (fT4) and TSH values
following overnight fasting of 12 hour. fT4 and TSH levels were
estimated by chemilumine-scence method using immunoassay
analyzer. Based on a school based Indian study, the reference
values of mean fT4 were 1.13-1.34 ng/dL for boys and 1.11-1.22
ng/dL for girls, and TSH 2.57-3.6 mIU/l for boys and 1.83-3.58
mIU/L for girls [4]. Children with TSH >15 mIU/L irrespective of
symptoms and TSH between 10 -15 mIU/L with symptoms of
hypothyroidism were treated with thyroxine [11]. Lifestyle
modifications like healthy eating patterns, increased physical
activity and decreased sedentary behavior were advised to all
participants. Children with SCH (TSH 5-15 mIU/L) were followed
up for a period of one year and serum TSH levels were repeated.
Statistical analysis: Data entry was done
in MS Excel 2010. Data was analyzed using SPSS version 16.0.
Pearson correlation coefficient was used for correlation
studies.Wilcoxon signed rank test was applied for comparing
baseline and follow-up variables. Values of P<0.05 were
considered statistically significant.
RESULTS
Among 150 overweight and obese children
(49.3% males; mean age, 10.2 year) included in our study, 132
(88%) children were found to have a TSH value of 0-5 mIU/L (euthyroid);
17 (11.3%) had a TSH value corresponding to SCH levels with 15
(10%) having TSH between 5-10 mIU/L). One child (0.66%) had TSH
>15 mIU/L diagnosed as overt hypothyroidism and started on
thyroxine. The mean fT4 in subgroups with TSH 5-10 and 10-15 mIU/L
were 1.40 and 1.78 ng/dL, respectively. The mean (SD) BMI and
TSH of the study group were 23.78 (3.19) and 2.70 (2.44) mIU/L,
respectively. There was no association of TSH level with
overweight or obese children (P=0.56). The correlation
coefficient of BMI with fT4 and TSH were r=0.08 and r=0.016
(both P >0.05), respectively.
On follow-up of 17 children with SCH,10
(84.6%) had become euthyroid and 7 (15.4%) remained at
subclinical hypothyroid levels. None progressed to overt
hypothy-roidism.The mean (SD) baseline and following TSH values
were 6.33 (2.15) and 4.92 (2.14) (P=0.47). Comparison of
mean baseline BMI with follow-up BMI is given in Table
I. No correlation was found between weight loss and TSH
change (r=0.138; P=0.598).
Table I Baseline and Follow-up Body Mass Index (BMI) in Overweight and Obese Children
Aged 5-15 Year With Initial Thyroid Stimulating Hormone Level 5-15 mU/L (N=17)
|
BMI, kg/m2 |
|
P value |
Baseline TSH, |
Baseline |
Follow up
|
|
mIU/L |
mean (SD) |
mean (SD) |
|
TSH 5-10 |
22.48 (2.2) |
22.49 (2.1) |
0.56 |
TSH 10-15 |
25.62 (3.4) |
25.59 (3.1) |
0.42 |
DISCUSSION
Our study revealed majority (84.6 %) of obese
kids with SCH (TSH 5-15 mIU/L) reverted back to euthyroid state
within one year. In another study from India, among 40 children
(aged 2-16 years) presenting with subclinical hypothyroidism,
majority (52.5%) became euthyroid after the follow-up period of
3 months to 1 year, which was similar to our findings [14]. TSH
levels decreased in more than 80% of obese children following
life style interventions for obesity without thyroxine therapy
[15]. Weight reduction and TSH normalization were attained only
with diet and life style modifications [15]. In our study,
though TSH levels normalized in most of the children, majority
had no weight reduction on follow-up. This was mainly attributed
to lack of compliance to life style modifications and lack of
regular follow-up.
In this study, we found poor correlation
between BMI and TSH/T4 levels, whereas Ghergherehchi, et al.
[12] demonstrated that levels of TSH and fT4 were signi-ficantly
higher in children with obesity compared with the control [12].
In a study published from South Korea, BMI was positively
correlated with serum concentrations of TSH and negatively
correlated with serum concentrations of fT4 after adjusting for
age [13]. In this study, we could not demonstrate the
relationship between baseline BMI and baseline TSH, which is
discordant with many similar studies, which have confirmed the
increasing TSH levels with BMI. Similarly, fT4 levels were not
associated with BMI in our study though some studies revealed a
positive or negative correlation with BMI [12,13].
Relatively smaller sample size and lack of
autoimmune thyroid profile data in the study population are some
of the limitations of this study. Further multi-centric studies
with long term follow-up are needed to detail the cause of
hypothyroidism among obese children, and course of
thyrotropinemia in adolescence and young adulthood.
Acknowledgement: Mrs Poovitha,
Statistician, Indira Gandhi Medical College and Research
Institute, Puducherry, India.
Contributors: ST,AT: conceived the study;
ST, RB: collected data and managed the cases; ST,RB: reviewed
the literature and drafted the initial version of the
manuscript; AT contributed to literature review and critically
revised the manuscript. All authors contributed to drafting of
the manuscript and approved the final version of the manuscript.
Ethics approval: Institute Ethics
committee IGMC&RI, Puducherry; No. 06/IEC/IGMC&RI/F-7/2018 dated
June 6, 2018.
Funding: None; Competing interests:
None stated.
|
What This Study Adds?
•
Subclinical hypothyroid
levels of TSH (5-15 mIU/L) were common in overweight and
obese children, and reverted back to normal after a
one-year follow-up.
|
REFERENCES
1. Ministry of Health and Family Welfare (MoHFW),
Government of India, UNICEF andpopulation Council, 2019.
Comprehensive National Nutrition Survey (CNNS) National Report,
New Delhi. Available from:
https://www.popcouncil.org/uploads/pdfs/2019RH_CNNS report.pdf.
Accessed January 6, 2020.
2. Shriraam M, Sridhar M. Subclinical
hypothyroidism in children. Indian Pediatr. 2014;51:889-95.
3. Marwaha RK, Tandon N, Desai A,
et al. Reference range of thyroid hormones in normal Indian
school-age children. ClinEndocrinol.2008; 68:369-74.
4. Marwaha RK, Tandon N, Garg MK, Ganie MA,
Narang A, Mehan N, et al. Impact of body mass index on
thyroid fun-ctions in Indian children. ClinEndocrinol.
2013;79:424-8.
5. Thiagarajan S, Arunbabu T, Balaji R.
Subclinical hypo-thyroidism in obese South Indian children.
Indian J Pediatr. 2019;86:662.
6. Longhi S, Radetti G. Thyroid function and
obesity. J Clin Res Pediatr Endocrinol. 2013;5:40-4.
7. Aypak C, Turedi O, Yuce A, Gorepelioglu S.
Thyroid-stimulating hormone (TSH) level in nutritionally obese
children and metabolic co-morbidity. J Pediatr Endocrinol Metab.
2013;26:703-8.
8. Reinehr T, de Sousa G, Andler.
Hyperthyrotropinemia in obese children is reversible after
weight loss and is not related to lipids. J Clin Endocrinol
Metab. 2006;91: 3088-91.
9. Wasniewska M, Corrias A, Aversa T, Valenzise
M, Mussa A, De Martino L, et al. Comparative evaluation
of therapy with L-Thyroxine versus no treatment in
children with idiopathic and mild subclinical hypothyroidism.
Horm Res Paediatr. 2012;77:376-81.
10. Khadilkar V, Yadav S, Agrawal KK, Tamboli
S, Banerjee M, Cherian A, et al. Revised IAP growth
charts for height, weight and body mass index for 5- to
18-year-old Indian children. Indian Pediatr. 2015;52:47-55.
11. Jonklaas J, Bianco AC, Bauer AJ, Burman
KD, Cappola AR, Celi FS, et al. Guidelines for the
Treatment of Hypo-thyroidism: Prepared by the American Thyroid
Asso-ciation Task Force on Thyroid Hormone Replacement. Thyroid.
2014;24:1670-751.
12. Ghergherehchi R, Nazanin H. Thyroid
hormonal status among children with obesity. Ther Adv Endocrinol
Metab. 2015;6:51-5.
13. Jin HY. Prevalence of subclinical
hypothyroidism in obese children or adolescents and association
between thyroid hormone and the components of metabolic
syndrome. J Paediatr Child Health. 2018;54:975-80.
14. Sridhar M, Mahadevan S, Vishwanathan L,
Subbarayan A. Subclinical hypothyroidism: A prospective
observational study from Southern India. Indian
Pediatr.2014;55:219-21.
15. Matusik P, Gawlik A,
Januszek-Trzciakowska A, Malecka-Tendera E. Isolated subclinical
hyperthyrotro-pinemiain obese children: Does levothyroxine (LT4)
improve weight reduction during combined behavioral therapy? Int
J Endocrinol. 2015;2015:792509.
|
|
 |
|